OSTX OS Therapies Inc

Price (delayed)

$1.87

Market cap

$83.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$83.71M

?
Relative Growth: Rel. Growth: 7
Relative Strength: Rel. Strength: 62
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address ...

Highlights
The quick ratio has soared by 150% QoQ but it has shrunk by 94% YoY
The EPS has increased by 14% year-on-year but it has declined by 10% since the previous quarter
The equity has dropped by 159% year-on-year and by 78% since the previous quarter
OS Therapies's net income has decreased by 23% from the previous quarter

Key stats

What are the main financial stats of OSTX

OSTX stock price

How has the OS Therapies stock price performed over time
Intraday
3.89%
1 week
-5.56%
1 month
12.65%
1 year
12.65%
YTD
33.57%
QTD
32.62%

Financial performance

How have OS Therapies's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.87M
Net income
-$35.27M
Gross margin
N/A
Net margin
N/A
OS Therapies's net income has decreased by 23% from the previous quarter
The operating income has contracted by 18% from the previous quarter

Price vs fundamentals

How does OSTX's price correlate with its fundamentals

Growth

What is OS Therapies's growth rate over time

Valuation

What is OS Therapies stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 14% year-on-year but it has declined by 10% since the previous quarter
The equity has dropped by 159% year-on-year and by 78% since the previous quarter

Efficiency

How efficient is OS Therapies business performance
The ROA has contracted by 23% YoY and by 11% from the previous quarter

Dividends

What is OSTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OSTX.

Financial health

How did OS Therapies financials performed over time
OS Therapies's total assets is 57% lower than its total liabilities
The quick ratio has soared by 150% QoQ but it has shrunk by 94% YoY
OSTX's current ratio has dropped by 96% year-on-year but it has surged by 67% since the previous quarter
OS Therapies's debt is 112% more than its equity
The equity has dropped by 159% year-on-year and by 78% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.